drugset / Trial / NCT01686711
A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322
Parallel-groupTreatment
Summary
To evaluate the efficacy and safety of coadministration AD-4833 and SYR-322 in patients with diabetes mellitus.
Timeline
- Start
- 2012-09
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 15 mg | Oral |
| Subject | Pioglitazone | Small molecule | 30 mg | Oral |